BMC Medicine

official impact factor 5.75

Open Access Highly Access Email this article to a friend

Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials

Clive E Adams*, John Rathbone, Ben Thornley, Mike Clarke, Jo Borrill, Kristian Wahlbeck and A George Awad

BMC Medicine 2005, 3:15 doi:10.1186/1741-7015-3-15

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.